Mirae Asset Global Investments Co., Ltd. Krystal Biotech, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,116 shares of KRYS stock, worth $211,013. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,116
Previous 964
15.77%
Holding current value
$211,013
Previous $173,000
11.56%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding KRYS
# of Institutions
314Shares Held
24.7MCall Options Held
418KPut Options Held
485K-
Black Rock Inc. New York, NY3.95MShares$746 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.82MShares$534 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.66MShares$503 Million6.67% of portfolio
-
State Street Corp Boston, MA1.36MShares$256 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA942KShares$178 Million0.02% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.85B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...